Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
BMC Musculoskeletal Disorders
|
April 11, 2019
Impact of compression stockings on leg swelling after arthroscopy - a prospective randomised pilot study
Tina S Tischer, Sebastian Oye, Robert Lenz, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA
|
September 1, 2022
Knot tying in arthroplasty and arthroscopy causes lesions to surgical gloves: a potential risk of infection
Andreas Enz, Annett Klinder, Lucas Bisping, et al.
European Radiology
|
May 5, 2023
Comparison between dedicated MRI and symphyseal fluoroscopic guided contrast agent injection in the diagnosis of cleft sign in athletic groin pain and association with pelvic ring instability
Norman Holl, Judith Sarah Gerhardt, Thomas Tischer, et al.
Headache
|
October 16, 2019
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults
Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Cephalalgia : an International Journal of Headache
|
April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Peter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 4, 2011
Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels
Jinhe Li, Daniel A Llano, Teresa Ellis, et al.
The Lancet. Neurology
|
May 3, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper, Messoud Ashina, Uwe Reuter, et al.
The Lancet. Neurology
|
February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun, David W Dodick, Stephen Silberstein, et al.
Cephalalgia : an International Journal of Headache
|
July 10, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, et al.
Neurology
|
April 19, 2019
Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study
Richard B Lipton, Stewart J Tepper, Uwe Reuter, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
BMC Musculoskeletal Disorders
|
April 11, 2019
Impact of compression stockings on leg swelling after arthroscopy - a prospective randomised pilot study
Tina S Tischer, Sebastian Oye, Robert Lenz, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA
|
September 1, 2022
Knot tying in arthroplasty and arthroscopy causes lesions to surgical gloves: a potential risk of infection
Andreas Enz, Annett Klinder, Lucas Bisping, et al.
European Radiology
|
May 5, 2023
Comparison between dedicated MRI and symphyseal fluoroscopic guided contrast agent injection in the diagnosis of cleft sign in athletic groin pain and association with pelvic ring instability
Norman Holl, Judith Sarah Gerhardt, Thomas Tischer, et al.
Headache
|
October 16, 2019
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults
Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Cephalalgia : an International Journal of Headache
|
April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Peter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 4, 2011
Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels
Jinhe Li, Daniel A Llano, Teresa Ellis, et al.
The Lancet. Neurology
|
May 3, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper, Messoud Ashina, Uwe Reuter, et al.
The Lancet. Neurology
|
February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun, David W Dodick, Stephen Silberstein, et al.
Cephalalgia : an International Journal of Headache
|
July 10, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, et al.
Neurology
|
April 19, 2019
Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study
Richard B Lipton, Stewart J Tepper, Uwe Reuter, et al.
Page
of 3